Ampersand
Private equityBoston · Growth · 61 people tracked
Investment thesis
Ampersand Capital Partners is a middle-market private equity firm founded in 1988 that focuses exclusively on growth-oriented investments in the healthcare sector. Managing over $4 billion in assets, the firm combines private equity and operating experience to build value and drive long-term performance in partnership with portfolio company management teams. It has helped develop numerous market-leading companies across its core healthcare sectors, with operations spanning offices in Boston, Amsterdam, and London.
Source: firm website, verified Aug 6, 2026.
Team · 61 people
from the firm's websiteWhat they invest in
from 7 of 71 portfolio companiesMedical Devices ×5Biotech ×4Healthtech ×3Deep Tech ×2Advanced Manufacturing ×1AI & Machine Learning ×1Enterprise Software ×1Hardware ×1
HQs:United States×7
Investments · 71 tracked
founders shown can be your intro pathPerkinElmer is a scientific instrument and technology company that provides analytical tools and services for research, diagnostics, and life sciences applications.
BiotechDeep TechEnterprise SoftwareHealthtechMedical DevicesWaltham, US
Sylvie Gregoire(Director)Michel Vounatsos(Director)Samuel Chapin(Director)James M. Mock(Executive Officer)Andrew Okun(Executive Officer)Pascale Witz(Director)
Laboratory instrumentation CDMO, originally a supplier of mass spectrometry components, scaled globally via acquisitions and later sold to IMI.
Canopy Biosciences (Bruker Spatial Biology) develops spatial biology instruments and assays for analyzing gene expression, RNA, and proteins in tissue samples.
BiotechHealthtechMedical DevicesSaint Louis, US
EDWARD WEINSTEIN(President, Chief Executive Officer and Manager)CRYSTAL WINKELER(Chief Operating Officer)CHARLES BOLTEN(Director)DAVID KINGSLEY(Director)
BoardDAVID SMOLLER(Director)
DYNEX Technologies manufactures fully automated ELISA laboratory systems and diagnostic instruments for clinical and research laboratories.
Medical Devices
Designs and manufactures high-performance endoscopic stapling devices made in the USA for a wide range of surgical procedures.
Lexington Medical manufactures surgical staplers and stapling devices, including the AEON Endostapler for procedures like lung volume reduction surgery.
Advanced ManufacturingHardwareMedical DevicesBedford, US
Jameson Kief(Director of Engineering)David Roberts(Director)Leon Amariglio(Executive Officer, Director)Aaron Sandoski(Director)Doron Harlev(Director)David Lang(Director)
BiotechMarlborough, US
Peter Glick(Executive Officer, Director)James Jersey(Executive Officer, Director)Jessica Sullivan(Executive Officer)Glick Peter(Executive Officer, Director)
BoardHerbert Hooper(Director)
San Diego, US
Bridget Carragher(Director)John Rigg(Executive Officer, Director)Janine LeBlanc(Executive Officer)Peter H. Glick(Executive Officer, Director)Brian Conkle(Executive Officer)Jens Greiser(Director)
Fund performance · per public LP disclosures · 4
as of Mar 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Ampersand CF, L.P.LPs: Los Angeles County Employees Retirement Association | 2020 | — | 29.5% | 1.78x | 1.06x |
| Ampersand 2011LPs: New York City Employees' Retirement System, Teachers' Retirement System of the City of New York, New York City Police Pension Fund +1 more | 2011 | — | 21.8% | 3.24x | 3.24x |
| AmpersandLPs: North Carolina Retirement Systems | 2006 | — | 16.6% | 3.12x | 3.12x |
| Ampersand 2006LPs: New York City Employees' Retirement System, Teachers' Retirement System of the City of New York | 2006 | — | 16.9% | 3.12x | 3.12x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- What stage does Ampersand invest at?
- Ampersand invests at the Growth stage.
- What sectors does Ampersand focus on?
- Ampersand focuses on Biotech, Healthtech, Medical Devices.
- Where is Ampersand located?
- Ampersand is headquartered in Boston, US.
Images
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital is a venture and growth investment firm that backs technology companies, including a dedicated Resilience Tech practice focused on energy, industrial and infrastructure systems.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.